<SEC-DOCUMENT>0001437749-25-035656.txt : 20251119
<SEC-HEADER>0001437749-25-035656.hdr.sgml : 20251119
<ACCEPTANCE-DATETIME>20251119083019
ACCESSION NUMBER:		0001437749-25-035656
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20251117
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251119
DATE AS OF CHANGE:		20251119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEVA INC
		CENTRAL INDEX KEY:			0001173489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		ORGANIZATION NAME:           	06 Technology
		EIN:				770556376
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49842
		FILM NUMBER:		251496685

	BUSINESS ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-308-8328

	MAIL ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA  INC
		DATE OF NAME CHANGE:	20031208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PARTHUSCEVA INC
		DATE OF NAME CHANGE:	20021101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA INC
		DATE OF NAME CHANGE:	20020515
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ceva20251118_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ceva="http://www.ceva.com/20251117"><head>
	<title>ceva20251118_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 11/19/2025 2:06:34 AM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-252">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-253">0001173489</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ceva-20251117.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-11-17</xbrli:startDate>
<xbrli:endDate>2025-11-17</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND</b> <b>EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-263">8-K</ix:nonNumeric> </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: Times New Roman; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family: Times New Roman; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-264">November 17, 2025</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-265">CEVA, INC.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-266">Delaware</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-267">000-49842</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-268">77-0556376</ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(State or Other Jurisdiction of Incorporation)</div>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-269">15245 Shady Grove Road</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine2" id="ixv-270">Suite 400</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-271">Rockville</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressStateOrProvince" id="ixv-272">MD</ix:nonNumeric> <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-273">20850</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Offices, and Zip Code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-274">240</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-275">308-8328</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registrant&#8217;s Telephone Number, Including Area Code</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Not applicable</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-276">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-277">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-278">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-279">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Title of each class</b></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 32%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Trading Symbol(s)</b></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-280">Common Stock</ix:nonNumeric>, $0.001 par value</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 32%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-281">CEVA</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">The <ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-282">Nasdaq</ix:nonNumeric> Global Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-283">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">On November 18, 2025, Ceva, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with J.P. Morgan Securities LLC, as representative of the underwriters (the &#8220;Underwriters&#8221;). Pursuant to the terms and conditions of the Underwriting Agreement, the Company agreed to sell 3,000,000 shares of its common stock, $0.001 par value per share (&#8220;Common Stock&#8221;), at a public offering price of $19.50. Pursuant to the terms of the Underwriting Agreement, the Company granted the Underwriters a 30-day option to purchase up to an additional 450,000 shares of Common Stock. The Common Stock was offered and sold pursuant to a prospectus supplement, dated November 18, 2025, and a shelf registration statement on Form S-3 (File No.&#160;333-281323), which became effective on August 16, 2024. The closing of the offering is expected to occur on November 20, 2025.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">A copy of the Underwriting Agreement is filed herewith as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The summary set forth above is qualified in its entirety by reference to Exhibit&#160;1.1.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">Morrison &amp; Foerster LLP, counsel to the Company, delivered an opinion as to the legality of the issuance and sale of Common Stock in the offering, a copy of which is attached hereto as Exhibit 5.1 and is incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 8.01. Other Events.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">On November 17, 2025, the Company issued a press release announcing the commencement of the offering, and on November 18, 2025, the Company issued a press release announcing the pricing of the offering. A copy of each press release is attached as Exhibit 99.1 and 99.2, respectively, to this Current Report on Form 8-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 9.01</b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(d)&#160;Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1</div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_890640.htm" style="-sec-extract:exhibit;">Underwriting Agreement, dated November 18, 2025, by and among Ceva, Inc. and J.P. Morgan Securities LLC, as representative of the underwriters.</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.1</div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_890610.htm" style="-sec-extract:exhibit;">Opinion of Morrison &amp; Foerster LLP regarding the legality of the Common Stock.</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_890437.htm" style="-sec-extract:exhibit;">Press Release dated November 17, 2025, announcing the commencement of the offering.</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">99.2</div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_890611.htm" style="-sec-extract:exhibit;">Press Release dated November 18, 2025, announcing the pricing of the offering.</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 94%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: center;"><b>CEVA, INC.</b></div>

<div style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: center;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 50%;">Date: November 18, 2025</td>
			<td style="vertical-align: bottom; width: 3%;">&#160;</td>
			<td style="vertical-align: bottom; width: 47%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>
			</td>
			<td style="vertical-align: bottom; width: 3%;">By:</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Yaniv Arieli</div>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align: top; width: 50%;">&#160;</td>
			<td style="vertical-align: top; width: 3%;">&#160;</td>
			<td style="vertical-align: bottom; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yaniv Arieli</div>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align: top; width: 50%;">&#160;</td>
			<td style="vertical-align: top; width: 3%;">&#160;</td>
			<td style="vertical-align: bottom; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex_890640.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html><head>
	<title>ex_890640.htm</title>

	<!-- Generated by ThunderDome Portal - 11/19/2025 2:58:36 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 1.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, INC.</b><br>
<br>
3,000,000 Shares of Common Stock</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Underwriting Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">November 18, 2025</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">J.P. Morgan Securities LLC<br>
As Representative of the<br>
several Underwriters listed<br>
in Schedule 1 hereto</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">c/o</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">J.P. Morgan Securities LLC</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">270 Park Avenue</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">New York, New York 10017</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Ceva, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the &#8220;<u>Underwriters</u>&#8221;), for whom you are acting as representative (the &#8220;<u>Representative</u>&#8221;), an aggregate of 3,000,000 shares of common stock, par value $0.001 per share (&#8220;<u>Common Stock</u>&#8221;), of the Company (the &#8220;<u>Underwritten Shares</u>&#8221;) and, at the option of the Underwriters, up to an additional 450,000 shares of Common Stock of the Company (the &#8220;<u>Option Shares</u>&#8221;). The Underwritten Shares and the Option Shares are herein referred to as the &#8220;<u>Shares</u>&#8221;. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the &#8220;<u>Stock</u>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company hereby confirms its agreement with the several Underwriters concerning the purchase and sale of the Shares, as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration Statement</u>. The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;<u>Securities Act</u>&#8221;), a registration statement on Form S-3 (File No. 333-281323), including a prospectus, relating to the Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (&#8220;<u>Rule 430 Information</u>&#8221;), is referred to herein as the &#8220;<u>Registration Statement</u>&#8221;; and as used herein, the term &#8220;<u>Preliminary Prospectus</u>&#8221; means each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term &#8220;<u>Prospectus</u>&#8221; means the prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the &#8220;<u>Rule 462 Registration Statement</u>&#8221;), then any reference herein to the term &#8220;<u>Registration Statement</u>&#8221; shall be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting agreement (this &#8220;<u>Agreement</u>&#8221;) to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#8220;amend&#8221;, &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;<u>Exchange Act</u>&#8221;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">At or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex A, the &#8220;<u>Pricing Disclosure Package</u>&#8221;): a Preliminary Prospectus dated November 17, 2025 and each &#8220;free-writing prospectus&#8221; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><u>&#8220;Applicable Time</u>&#8221; means 5:00 P.M., New York City time, on November 18, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase of the Shares</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $18.525 (the &#8220;<u>Purchase Price</u>&#8221;) from the Company the respective number of Underwritten Shares set forth opposite such Underwriter&#8217;s name in Schedule 1 hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In addition, the Company agrees to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representative in its sole discretion shall make.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date of the Prospectus, by written notice from the Representative to the Company. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section 10 hereof). Any such notice shall be given at least two business days prior to the date and time of delivery specified therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Payment for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representative in the case of the Underwritten Shares, at the offices of Latham &amp; Watkins LLP, 1271 Avenue of the Americas, New York, New York 10020 at 10:00 A.M. New York City time on November 20, 2025, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Company may agree upon in writing or, in the case of the Option Shares, on the date and at the time and place specified by the Representative in the written notice of the Underwriters&#8217; election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the &#8220;<u>Closing Date</u>&#8221;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#8220;<u>Additional Closing Date</u>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representative for the respective accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#8220;<u>DTC</u>&#8221;) unless the Representative shall otherwise instruct.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company acknowledges and agrees that the Representative and the other Underwriters are acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, neither the Representative nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representative nor the other Underwriters shall have any responsibility or liability to the Company with respect thereto. Any review by the Representative and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations and Warranties of the Company</u>. The Company represents and warrants to each Underwriter that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(a)<i>&nbsp;&nbsp;&nbsp;&nbsp;Preliminary Prospectus.</i> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <u>provided</u> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(b)<i>&nbsp;&nbsp;&nbsp;&nbsp;Pricing Disclosure Package</i>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <u>provided</u> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(c)<i>&nbsp;&nbsp;&nbsp;&nbsp;Issuer Free Writing Prospectus. </i>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#8220;written communication&#8221; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an &#8220;<u>Issuer Free Writing Prospectus</u>&#8221;) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic road show and any other written communications approved in writing in advance by the Representative. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <u>provided</u> that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(d)<i>&nbsp;&nbsp;&nbsp;&nbsp;Testing-the-Waters Materials. </i>The Company (i) has not alone engaged in any Testing-the-Waters Communications and (ii) has not authorized anyone to engage in Testing-the-Waters Communications. The Company has not distributed or approved for distribution any Written Testing-the-Waters Communications. &#8220;<u>Written Testing-the-Waters Communication</u>&#8221; means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(e)<i>&nbsp;&nbsp;&nbsp;&nbsp;Registration Statement and Prospectus.</i> The Registration Statement has been declared effective by the Commission. No order suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to the offering of the Shares has, to the Company&#8217;s knowledge, been initiated or threatened by the Commission; as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus complied and will comply in all material respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <u>provided</u> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(f)<i>&nbsp;&nbsp;&nbsp;&nbsp;Incorporated Documents.</i> The documents incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and, except as set forth in any amendments to such documents filed with the Commission, none of such documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(g)<i>&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements.</i> The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly in all material respects the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles (&#8220;<u>GAAP</u>&#8221;) in the United States applied on a consistent basis throughout the periods covered thereby, and any supporting schedules included or incorporated by reference in the Registration Statement present fairly in all material respects the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby; all disclosures included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(h)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Material Adverse Change.</i> Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i) there has not been any material change in the capital stock (other than the issuance of shares of Common Stock upon exercise of stock options or settlement of awards described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Organization and Good Standing.</i> The Company and each of its subsidiaries have been duly organized and are validly existing and, to the extent applicable, in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing, to the extent applicable, in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement (a &#8220;<u>Material Adverse Effect</u>&#8221;). The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21.1 to the Company&#8217;s most recent Annual Report on Form 10-K.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(j)<i>&nbsp;&nbsp;&nbsp;&nbsp;Capitalization.</i> The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#8220;Description of Capital Stock&#8221;; all the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and all the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly and validly authorized and issued, are fully paid and non-assessable (except, in the case of any foreign subsidiary, for directors&#8217; qualifying shares and except as otherwise described in the Registration Statement, the Pricing Disclosure Package and the Prospectus) and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(k)<i>&nbsp;&nbsp;&nbsp;&nbsp;Stock Options. </i>With respect to the stock options (the &#8220;<u>Stock Options</u>&#8221;) granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the &#8220;<u>Company Stock Plans</u>&#8221;), (i) each Stock Option intended to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code so qualifies, (ii) each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be effective (the &#8220;<u>Grant Date</u>&#8221;) by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the Nasdaq Global Market and any other exchange on which Company securities are traded, and (iv)&nbsp;each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the Company and disclosed in the Company&#8217;s filings with the Commission in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations or prospects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(l)<i>&nbsp;&nbsp;&nbsp;&nbsp;Due Authorization.</i> The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(m)<i>&nbsp;&nbsp;&nbsp;&nbsp;Underwriting Agreement. </i> This Agreement has been duly authorized, executed and delivered by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(n)<i>&nbsp;&nbsp;&nbsp;&nbsp;The Shares. </i>The Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform to the descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(o)<i>&nbsp;&nbsp;&nbsp;&nbsp;Description of the Underwriting Agreement.</i> This Agreement conforms in all material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(p)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Violation or Default.</i> Neither the Company nor any of its subsidiaries is (i)&nbsp;in violation of its charter or by-laws or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(q)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Conflicts. </i>The execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the consummation of the transactions contemplated by this Agreement or the Pricing Disclosure Package and the Prospectus will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(r)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Consents Required.</i> No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the consummation of the transactions contemplated by this Agreement, except for the registration of the Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by FINRA and under applicable state securities laws in connection with the purchase and distribution of the Shares by the Underwriters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(s)<i>&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings.</i> Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#8220;<u>Actions</u>&#8221;) pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, would reasonably be expected to have a Material Adverse Effect; no such Actions are threatened or, to the knowledge of the Company, contemplated by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(t)<i>&nbsp;&nbsp;&nbsp;&nbsp;Independent Accountants</i>. Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, who have certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(u)<i>&nbsp;&nbsp;&nbsp;&nbsp;Title to Real and Personal Property</i>. The Company and its subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or (ii) could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(v)<i>&nbsp;&nbsp;&nbsp;&nbsp;Intellectual Property</i>. (i) The Company and its subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names and other source indicators, copyrights and copyrightable works, know-how, trade secrets, software, systems, procedures, proprietary or confidential information and all other intellectual property rights (collectively, &#8220;<u>Intellectual Property</u>&#8221;) used in or necessary for the conduct of their respective businesses as currently conducted by them; (ii) the Company&#8217;s and its subsidiaries&#8217; conduct of their respective businesses does not infringe, misappropriate or otherwise violate any Intellectual Property rights of any third party; (iii) the Company and its subsidiaries have not received any written notice of any threatened action, suit, proceeding or claim challenging the validity, scope of enforceability of any Intellectual Property owned by the Company or any of its subsidiaries; (iv) to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being infringed, misappropriated, diluted or otherwise violated by any third party in any material respect; (v) all employees or contractors engaged in the development of Intellectual Property on behalf of the Company or any subsidiary of the Company have executed an invention assignment agreement whereby such employees or contractors presently assign all of their right, title and interest in and to such Intellectual Property to the Company or the applicable subsidiary if such Intellectual Property Rights are not assigned by operation of applicable law, and to the Company&#8217;s knowledge no such agreement has been breached or violated and (vi) the Company and its subsidiaries use, and have used, commercially reasonable efforts to maintain and protect the confidentiality of all their information intended to be maintained as a trade secret.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(w)<i>&nbsp;&nbsp;&nbsp;&nbsp;Open Source Software</i>. (i) The Company and its subsidiaries use and have used any and all software and other materials distributed under a &#8220;free,&#8221; &#8220;open source,&#8221; or similar licensing model (including but not limited to the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public License) (&#8220;<u>Open Source Software</u>&#8221;) in compliance with all license terms applicable to such Open Source Software; and (ii) neither the Company nor any of its subsidiaries use or distributes or has distributed any Open Source Software in any manner that requires or has required (A) the Company or any of its subsidiaries to permit reverse engineering of any software code or other technology owned by the Company or any of its subsidiaries or (B) any software code or other technology owned by the Company or any of its subsidiaries to be (1) disclosed or distributed in source code form, (2) licensed for the purpose of making derivative works or (3) redistributed at no charge.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(x)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Undisclosed Relationships</i>. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(y)<i>&nbsp;&nbsp;&nbsp;&nbsp;Investment Company Act</i>. The Company is not and, after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be required to register as an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;<u>Investment Company Act</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(z)<i>&nbsp;&nbsp;&nbsp;&nbsp;Taxes.</i> The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to be paid or filed through the date hereof (taking into account any duly obtained extensions); and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is no tax deficiency that has been, or would reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets, except those that would not, singularly or in the aggregate, have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(aa)<i>&nbsp;&nbsp;&nbsp;&nbsp;Licenses and Permits.</i> The Company and its subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, have a Material Adverse Effect; and except as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license, sub-license, certificate, permit or authorization or has any reason to believe that any such license, sub-license, certificate, permit or authorization will not be renewed in the ordinary course, except where such revocation, modification or nonrenewal would not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(bb)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Labor Disputes.</i> No labor disturbance by or dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its or its subsidiaries&#8217; principal suppliers, contractors or customers, except as would not have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of cancellation or termination with respect to any collective bargaining agreement to which it is a party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(cc)<i>&nbsp;&nbsp;&nbsp;&nbsp;Certain Environmental Matters</i>. (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;<u>Environmental Laws</u>&#8221;); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii) except as described in each of the Pricing Disclosure Package and the Prospectus, (x) there is no proceeding that is pending, or that is known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (y) the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that would reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z) none of the Company or its subsidiaries anticipates material capital expenditures relating to any Environmental Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(dd)<i>&nbsp;&nbsp;&nbsp;&nbsp;Compliance with ERISA</i>. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<u>ERISA</u>&#8221;), for which the Company or any member of its &#8220;Controlled Group&#8221; (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended (the &#8220;<u>Code</u>&#8221;)) would have any liability (each, a &#8220;<u>Plan</u>&#8221;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in &#8220;at risk status&#8221; (within the meaning of Section 303(i) of ERISA) and no Plan that is a &#8220;multiemployer plan&#8221; within the meaning of Section 4001(a)(3) of ERISA is in &#8220;endangered status&#8221; or &#8220;critical status&#8221; (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no &#8220;reportable event&#8221; (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation, in the ordinary course and without default) in respect of a Plan (including a &#8220;multiemployer plan&#8221; within the meaning of Section 4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions made in the Company&#8217;s and its Controlled Group affiliates&#8217; most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries&#8217; &#8220;accumulated post-retirement benefit obligations&#8221; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ee)<i>&nbsp;&nbsp;&nbsp;&nbsp;Disclosure Controls</i>. The Company and its subsidiaries maintain an effective system of &#8220;disclosure controls and procedures&#8221; (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ff)<i>&nbsp;&nbsp;&nbsp;&nbsp;Accounting Controls.</i> The Company and its subsidiaries maintain systems of &#8220;internal control over financial reporting&#8221; (as defined in Rule 13a-15(f) of the Exchange Act) that has been designed to comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no material weaknesses in the Company&#8217;s internal controls. The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(gg)<i>&nbsp;&nbsp;&nbsp;&nbsp;eXtensible Business Reporting Language.</i> The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(hh)<i>&nbsp;&nbsp;&nbsp;&nbsp;Insurance. </i>The Company and its subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ii)<i>&nbsp;&nbsp;&nbsp;&nbsp;Cybersecurity; Data Protection. </i>The Company and its subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;<u>IT Systems</u>&#8221;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and to the Company&#8217;s knowledge, are free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (collectively, &#8220;<u>Personal Data</u>&#8221;)) used in connection with their businesses, and there have been no security incidents, breaches, violations, outages or unauthorized uses of or accesses to any IT System or Personal Data, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. The Company and its subsidiaries have taken all necessary actions to prepare to comply with the European Union General Data Protection Regulation (and all other applicable laws and regulations with respect to Personal Data that have been announced as of the date hereof as becoming effective within 12 months after the date hereof, and for which any non-compliance with the same would be reasonably likely to create a material liability) as soon as they take effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(jj)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Unlawful Payments.</i> Neither the Company nor any of its subsidiaries nor any director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(kk)<i>&nbsp;&nbsp;&nbsp;&nbsp;Compliance with Anti-Money Laundering Laws</i>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#8220;<u>Anti-Money Laundering Laws</u>&#8221;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ll)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Conflicts with Sanctions Laws. </i>Neither the Company nor any of its subsidiaries, directors or officers, nor, to the knowledge of the Company, any employee, agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently (i) the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<u>OFAC</u>&#8221;) or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council (&#8220;<u>UNSC</u>&#8221;), the European Union, or the United Kingdom (including, without limitation, His Majesty&#8217;s Treasury (&#8220;<u>HMT</u>&#8221;)) or other relevant sanctions authority (collectively, &#8220;<u>Sanctions</u>&#8221;), (ii) located, operating, organized or resident in a country or territory that is the subject or target of comprehensive Sanctions, including, without limitation, the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, Cuba, Iran, North Korea and Syria (each, a &#8220;<u>Sanctioned Country</u>&#8221;); (iii) the government of a Sanctioned Country or the Government of Venezuela, or (iv) controlled, acting or behalf of, or 50% or more owned by any such persons or entities in the aggregate (each of (i)-(iv), a &#8220;<u>Sanctioned Person</u>&#8221;). The Company, its subsidiaries, directors, officers, employees, and, to the knowledge of the Company, its agents, affiliates and other persons associated with or acting on behalf of the Company or any of its subsidiaries are in compliance with applicable Sanctions. The Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (x) to fund, finance, or facilitate any activities, transactions, or business of or with any Sanctioned Person, (y) to fund or facilitate any activities or business in or of any Sanctioned Country or (z) in any other manner that would result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of applicable Sanctions. Since April 24, 2019, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(mm)<i>&nbsp;&nbsp;&nbsp;&nbsp;Covered Foreign Person.</i> Neither the Company nor any of its subsidiaries is a &#8220;covered foreign person&#8221;, as such term is defined in Executive Order 14105 on <i>Addressing United States Investments in Certain National Security Technologies and Products in Countries of Concern</i>, 88 Fed. Reg. 54867 (Aug. 9, 2023), including all implementing regulations thereof<i> </i>(the &#8220;<u>Outbound Investment Rules</u>&#8221;). Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company will result in the establishment of a &#8220;covered foreign person&#8221; or the engagement by a &#8220;person of a country of concern&#8221; in a &#8220;covered activity,&#8221; as each such term is defined in the Outbound Investment Rules. Neither the Company nor any of its subsidiaries currently engage, or have plans to engage, directly or indirectly, in a &#8220;covered activity,&#8221; as such term is defined in the Outbound Investment Rules.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(nn)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Restrictions on Subsidiaries</i>. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#8217;s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#8217;s properties or assets to the Company or any other subsidiary of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(oo)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Broker</i>&#8217;<i>s Fees.</i> Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Underwriter for a brokerage commission, finder&#8217;s fee or like payment in connection with the offering and sale of the Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(pp)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Registration Rights</i>. No person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(qq)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Stabilization.</i> Neither the Company nor any of its subsidiaries or affiliates has taken, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(rr)<i>&nbsp;&nbsp;&nbsp;&nbsp;Margin Rules</i>. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ss)<i>&nbsp;&nbsp;&nbsp;&nbsp;Forward-Looking Statements.</i> No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(tt)<i>&nbsp;&nbsp;&nbsp;&nbsp;Statistical and Market Data.</i> Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and market-related data included or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(uu)<i>&nbsp;&nbsp;&nbsp;&nbsp;Sarbanes-Oxley Act</i>. There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the &#8220;<u>Sarbanes-Oxley Act</u>&#8221;), including Section 402 related to loans and Sections 302 and 906 related to certifications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(vv)<i>&nbsp;&nbsp;&nbsp;&nbsp;Status under the Securities Act</i>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or any offering participant made a <i>bona fide</i> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in any event prior to the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ww)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Ratings</i>. There are (and prior to the Closing Date, and the Additional Closing Date, as the case may be, will be) no debt securities, convertible securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a &#8220;nationally recognized statistical rating organization&#8221;, as such term is defined in Section 3(a)(62) under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Agreements of the Company</u>. The Company covenants and agrees with each Underwriter that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(a)<i>&nbsp;&nbsp;&nbsp;&nbsp;Required Filings.</i> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; and the Company will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representative may reasonably request. The Company will pay the registration fee for this offering within the time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(b)<i>&nbsp;&nbsp;&nbsp;&nbsp;Delivery of Copies.</i> The Company will deliver without charge, (i) to the Representative, two signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Representative may reasonably request. As used herein, the term &#8220;<u>Prospectus Delivery Period</u>&#8221; means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(c)<i>&nbsp;&nbsp;&nbsp;&nbsp;Amendments or Supplements, Issuer Free Writing Prospectuses.</i> Before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company will furnish to the Representative and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representative reasonably objects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(d)<i>&nbsp;&nbsp;&nbsp;&nbsp;Notice to the Representative.</i> The Company will advise the Representative promptly, and confirm such advice in writing, (i) when the Registration Statement has become effective; (ii) when any amendment to the Registration Statement has been filed or becomes effective; (iii) when any supplement to the Pricing Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iv) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information; (v) of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vii) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (viii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of the Shares and, if any such order is issued, will obtain as soon as possible the withdrawal thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(e)<i>&nbsp;&nbsp;&nbsp;&nbsp;Ongoing Compliance.</i> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the Underwriters and to such dealers as the Representative may designate such amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at any time prior to the Closing Date or the Additional Closing Date, as the case may be, (i) any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representative may designate such amendments or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(f)<i>&nbsp;&nbsp;&nbsp;&nbsp;Blue Sky Compliance.</i> The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; <u>provided</u> that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(g)<i>&nbsp;&nbsp;&nbsp;&nbsp;Earning Statement. </i>The Company will make generally available to its security holders and the Representative as soon as practicable an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#8220;effective date&#8221; (as defined in Rule 158) of the Registration Statement, it being understood and agreed that such earning statement shall be deemed to have been made available by the Company if the Company is in compliance with its reporting obligations pursuant to the Exchange Act, if such compliance satisfies the conditions of Rule 158 and if such earnings statement is deemed to have been made available on the Commission&#8217;s Electronic Data Gathering, Analysis, and Retrieval system.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(h)<i>&nbsp;&nbsp;&nbsp;&nbsp;Clear Market.</i> For a period of 90 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of the Representative, other than the Shares to be sold hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:72pt;">The restrictions described above do not apply to (i) the issuance of shares of Stock or securities convertible into or exercisable for shares of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of RSUs or performance-based stock units (including net settlement), in each case outstanding on the date of this Agreement and described in the Prospectus; (ii) grants of stock options, stock awards, restricted stock, RSUs, performance-based stock units, or other equity awards and the issuance of shares of Stock or securities convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise of stock options or otherwise) to the Company&#8217;s employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the Closing Date and described in the Prospectus, provided that such recipients enter into a lock-up agreement with the Underwriters; (iii) the issuance of up to 5% of the outstanding shares of Stock, or securities convertible into, exercisable for, or which are otherwise exchangeable for, Stock, immediately following the closing of this offering, in acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up agreement with the Underwriters; or (iv) the filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Use of Proceeds.</i> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#8220;Use of Proceeds&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(j)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Stabilization.</i> Neither the Company nor its subsidiaries or affiliates will take, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(k)<i>&nbsp;&nbsp;&nbsp;&nbsp;Exchange Listing. </i>The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on the Nasdaq Global Market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(l)<i>&nbsp;&nbsp;&nbsp;&nbsp;Reports.</i> So long as the Shares are outstanding, the Company will furnish to the Representative, as soon as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <u>provided</u> the Company will be deemed to have furnished such reports and financial statements to the Representative to the extent they are filed on the Commission&#8217;s Electronic Data Gathering, Analysis, and Retrieval system.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(m)<i>&nbsp;&nbsp;&nbsp;&nbsp;Record Retention</i>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(n)<i>&nbsp;&nbsp;&nbsp;&nbsp;Shelf Renewal</i>. If immediately prior to the third anniversary (the &#8220;<u>Renewal Deadline</u>&#8221;) of the initial effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration statement relating to the Shares, in a form satisfactory to the Representative. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a new shelf registration statement relating to the Shares, in a form satisfactory to the Representative, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Agreements of the Underwriters</u>.Each Underwriter hereby represents and agrees that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;It has not and will not use, authorize use of, refer to or participate in the planning for use of, any &#8220;free writing prospectus&#8221;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i) a free writing prospectus that contains no &#8220;issuer information&#8221; (as defined in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show), or (iii) any free writing prospectus prepared by such Underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an &#8220;<u>Underwriter Free Writing Prospectus</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;It has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <i>provided</i> that Underwriters may use a term sheet substantially in the form of Annex B hereto without the consent of the Company; <i>provided further</i> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the first use of such term sheet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;It is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions of Underwriters</u><u>&#8217;</u><u> Obligations.</u> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(a)<i>&nbsp;&nbsp;&nbsp;&nbsp;Registration Compliance; No Stop Order.</i> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section 4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(b)<i>&nbsp;&nbsp;&nbsp;&nbsp;Representations and Warranties.</i> The representations and warranties of the Company contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(c)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Material Adverse Change.</i> No event or condition of a type described in Section 3(h) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(d)<i>&nbsp;&nbsp;&nbsp;&nbsp;Officer</i>&#8217;<i>s Certificate.</i> The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to the Representative (i) confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in Sections 3(b) and 3(e) hereof are true and correct, (ii) confirming that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii) to the effect set forth in paragraphs (a) and (c) above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(e)<i>&nbsp;&nbsp;&nbsp;&nbsp;Comfort Letters.</i> (i) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a &#8220;cut-off&#8221; date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(ii) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representative a certificate, dated the respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect to certain financial data contained in the Pricing Disclosure Package and the Prospectus, providing &#8220;management comfort&#8221; with respect to such information, in form and substance reasonably satisfactory to the Representative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(f)<i>&nbsp;&nbsp;&nbsp;&nbsp;Opinion and 10b-5 Statement of Counsel for the Company.</i> Morrison &amp; Foerster, counsel for the Company, shall have furnished to the Representative, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representative, to the effect set forth in Annex C hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(g)<i>&nbsp;&nbsp;&nbsp;&nbsp;Opinion and 10b-5 Statement of Counsel for the Underwriters.</i> The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion and 10b-5 statement, addressed to the Underwriters, of Latham &amp; Watkins LLP, counsel for the Underwriters, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(h)<i>&nbsp;&nbsp;&nbsp;&nbsp;No Legal Impediment to Issuance and Sale.</i> No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(i)<i>&nbsp;&nbsp;&nbsp;&nbsp;Good Standing</i>. The Representative shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(j)<i>&nbsp;&nbsp;&nbsp;&nbsp;Exchange Listing</i>. The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved for listing on the Nasdaq Global Market, subject to official notice of issuance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(k)<i>&nbsp;&nbsp;&nbsp;&nbsp;Lock-up Agreements</i>. The &#8220;lock-up&#8221; agreements, each substantially in the form of Exhibit A hereto, between you and certain shareholders, officers and directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">(l)<i>&nbsp;&nbsp;&nbsp;&nbsp;Additional Documents.</i> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representative such further certificates and documents as the Representative may reasonably request.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification and Contribution</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)<i>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of the Underwriters.</i> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any road show as defined in Rule 433(h) under the Securities Act (a &#8220;road show&#8221;) or any Pricing Disclosure Package, or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in paragraph (b) below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)<i>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of the Company.</i> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter: the concession and reallowance figures appearing in the third paragraph under the caption &#8220;Underwriting&#8221;, and the information contained in the seventh, fifteenth, sixteenth and eighteenth paragraphs under the caption &#8220;Underwriting&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)<i>&nbsp;&nbsp;&nbsp;&nbsp;Notice and Procedures.</i> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section 7, such person (the &#8220;<u>Indemnified Person</u>&#8221;) shall promptly notify the person against whom such indemnification may be sought (the &#8220;<u>Indemnifying Person</u>&#8221;) in writing; <u>provided</u> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under the preceding paragraphs of this Section 7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <u>provided</u>, <u>further</u>, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section 7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the reasonable and documented fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable and documented fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by J.P. Morgan Securities LLC and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemni&#8208;fied Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)<i>&nbsp;&nbsp;&nbsp;&nbsp;Contribution.</i> If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(e)<i>&nbsp;&nbsp;&nbsp;&nbsp;Limitation on Liability.</i> The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to paragraph (d) above were determined by <u>pro</u> <u>rata</u> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any reasonable and documented legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d) and (e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#8217; obligations to contribute pursuant to paragraphs (d) and (e) are several in proportion to their respective purchase obligations hereunder and not joint.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(f)<i>&nbsp;&nbsp;&nbsp;&nbsp;Non-Exclusive Remedies.</i> The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Effectiveness of Agreement</u>. This Agreement shall become effective as of the date first written above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination</u>. This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Defaulting Underwriter</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the non&#8209;defaulting Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#8220;<u>Underwriter</u>&#8221; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to purchase.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#8217;s pro rata share (based on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused by its default.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Payment of Expenses</u><i>.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&#8217;s counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Shares under the laws of such jurisdictions as the Representative may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriters);&nbsp;(vi) the cost of preparing stock certificates; (vii)&nbsp;the costs and charges of any transfer agent and any registrar; (viii) all expenses and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA (including the related fees and expenses of counsel for the Underwriters); (ix) all expenses incurred by the Company in connection with any &#8220;road show&#8221; presentation to potential investors; and (x) all expenses and application fees related to the listing of the Shares on the Nasdaq Global Market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If (i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Shares for delivery to the Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the reasonable and documented fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Persons Entitled to Benefit of Agreement</u>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival</u>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling persons or affiliates referred to in Section 7 hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">14.&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Defined Terms</u>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &#8220;affiliate&#8221; has the meaning set forth in Rule 405 under the Securities Act; (b) the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be closed in New York City; and (c) the term &#8220;<u>subsidiary</u>&#8221; has the meaning set forth in Rule 405 under the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">15.&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with USA Patriot Act</u>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">16.&nbsp;&nbsp;&nbsp;&nbsp;<u>Miscellaneous</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(a)<i>&nbsp;&nbsp;&nbsp;&nbsp;Notices.</i> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representative c/o J.P. Morgan Securities LLC, 270 Park Avenue, New York, New York 10017 (fax: (212) 622-8358); Attention: Equity Syndicate Desk. Notices to the Company shall be given to it at CEVA, Inc., 15245 Shady Grove Road, Suite 400, Rockville, MD 20850; Attention: Yaniv Arieli; email: Yaniv.arieli@ceva-ip.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">(b)<i>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law.</i> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Submission to Jurisdiction</i>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which the Company is subject by a suit upon such judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Waiver of Jury Trial.</i> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Recognition of the U.S. Special Resolution Regimes</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;">As used in this Section 16(g):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;"><u>&#8220;BHC Act Affiliate</u>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;"><u>&#8220;Covered Entity</u>&#8221; means any of the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 90pt;">(i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 90pt;">(ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 90pt;">(iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;"><u>&#8220;Default Right</u>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;"><u>&#8220;U.S. Special Resolution Regime</u>&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Counterparts.</i> This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Amendments or Waivers.</i> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Headings.</i> The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Very truly yours,</p>

			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&nbsp;</p>

			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">CEVA, INC.</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Yaniv Arieli</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Name: Yaniv Arieli</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Title: Chief Financial Officer</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accepted: As of the date first written above</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">J.P. MORGAN SECURITIES LLC</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For itself and on behalf of the<br>
several Underwriters listed<br>
in Schedule 1 hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Beau Freker&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u>&nbsp;&nbsp;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Beau Freker<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Executive Director</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Schedule 1</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5882352941177%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Underwriter</u></p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Number of Shares</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">J.P. Morgan Securities LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1,500,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">UBS Securities LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">450,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TD Securities (USA) LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">300,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stifel, Nicolaus &amp; Company, Incorporated</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">240,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Needham &amp; Company, LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">165,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rosenblatt Securities Inc.</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">120,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Roth Capital Partners, LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">120,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Loop Capital Markets LLC</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">105,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:50.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:50.8%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:50.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Total&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>
			</td>
			<td style="vertical-align:top;width:50.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3,000,000</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Annex A</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Pricing Disclosure Package</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">None.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">b. <b>Pricing Information Provided Orally by Underwriters</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Public Offering Price per Share: $19.50</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Number of Underwritten Shares: 3,000,000</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Number of Option Shares: 450,000 Annex B</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ceva, Inc.<br>
<br>
<u>Pricing Term Sheet</u><br>
<br>
<br>
None.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Annex C</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Form of Opinion of Counsel for the Company</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>[To be circulated separately]</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Exhibit A</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">FORM OF LOCK-UP AGREEMENT</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>[To be circulated separately]</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex_890610.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html><head>
	<title>ex_890610.htm</title>

	<!-- Generated by ThunderDome Portal - 11/19/2025 1:55:14 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 5.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 45%; vertical-align: top;">
			<div><img alt="mflogo.jpg" src="mflogo.jpg"></div>
			</td>
			<td style="width: 27%; vertical-align: top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">425 MARKET STREET<br>
			SAN FRANCISCO<br>
			CALIFORNIA&nbsp; 94105-2482</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">TELEPHONE: 415.268.7000</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">FACSIMILE: 415.268.7522</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">WWW.MOFO.COM</p>
			</td>
			<td style="width: 28%; vertical-align: top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: small-caps; margin: 0pt;">morrison &amp; foerster llp</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: small-caps; margin: 0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: small-caps; margin: 0pt;">amsterdam, austin, berlin, boston, brussels, denver, hong kong, london, los angeles, miami, new york, palo alto, san diego, san francisco, shanghai, singapore, tokyo, washington, d.c.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">November 18, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board of Directors</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ceva, Inc.<br>
15245 Shady Grove Road, Suite 400</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rockville, Maryland 20850</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Re: <u>Public Offering of Common Stock</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">We are acting as counsel to Ceva, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;), in connection with the issuance and sale by the Company of up to 3,000,000 shares of its common stock, $0.001 par value per share (the &#8220;<b>Shares</b>&#8221;), all of which Shares are to be sold by the Company pursuant to a prospectus supplement dated November 18, 2025 and the accompanying base prospectus dated August 16, 2024 (such documents, collectively, the &#8220;<b>Prospectus</b>&#8221;) that form part of the Company&#8217;s effective Registration Statement on Form S-3 (File No.&nbsp;333-281323) (the &#8220;<b>Registration Statement</b>&#8221;), filed by the Company with the United States Securities and Exchange Commission (the &#8220;<b>Commission</b>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">As counsel for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such agreements, instruments, documents, certificates and records as we have deemed relevant and necessary for the purposes of rendering this opinion and we are familiar with the proceedings taken and proposed to be taken by the Company in connection with the authorization, issuance and sale of the Shares. In our examination, we have assumed: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity with the originals of all documents submitted to us as copies; (iii) the truth, accuracy and completeness of the information, representations and warranties contained in the agreements, instruments, documents, certificates and records that we have reviewed; and (iv) the legal capacity of all natural persons. As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have not independently established or verified the facts so relied on. This opinion letter is given, and all statements herein are made, in the context of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="mflogo.jpg" src="mflogo.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Board of Directors</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Ceva, Inc.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">November 18, 2025</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Page Two</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">This opinion letter is based as to matters of law solely on the Delaware General Corporation Law, as amended. We express no opinion herein as to any other laws, statutes, ordinances, rules or regulations. As used herein, the term &#8220;Delaware General Corporation Law, as amended&#8221; includes the statutory provisions contained therein, all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting these laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that following (i)&nbsp;issuance and delivery of the Shares pursuant to the terms of the Underwriting Agreement, dated November 18, 2025, by and among the Company and the underwriters listed in Schedule 1 thereto, and (ii)&nbsp;receipt by the Company of the consideration for the Shares specified in the resolutions of the Board of Directors and the Pricing Committee of the Board of Directors, the Shares will be validly issued, fully paid and non-assessable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">This opinion is furnished to you in connection with the filing by the Company of a Current Report on Form 8-K relating to the offer and sale of the Shares, which Form 8-K will be incorporated by reference into the Registration Statement and Prospectus, and may not be relied upon for any other purpose without our express written consent. No opinion may be implied or inferred beyond the opinion expressly stated. This opinion is given as of the date hereof, and we assume no obligation to advise you of any changes in applicable law or any facts or circumstances that come to our attention after the date hereof that may affect the opinion contained herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">We hereby consent to the filing of this opinion as an exhibit to the above-described Current Report on Form 8-K and to the reference to our firm contained under the heading &#8220;Legal Matters&#8221; in the Prospectus. In giving this consent, we do not admit that we are in the category of persons whose consent is required by Section&nbsp;7 of the Securities Act or the rules and regulations promulgated by the Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 70%;">&nbsp;</td>
			<td style="width: 30%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Very truly yours,</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">/s/&nbsp;Morrison &amp; Foerster LLP</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Morrison &amp; Foerster LLP</p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex_890437.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_890437.htm</title>

	<!-- Generated by ThunderDome Portal - 11/18/2025 8:26:21 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">PRESS RELEASE</font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA ANNOUNCES COMMENCEMENT OF </b><br>
<b>UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK</b>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ROCKVILLE, MD, November 17, 2025 &#8212; Ceva, Inc. (NASDAQ: CEVA) today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock. Ceva has also agreed to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock. All of the shares to be sold in the proposed offering are to be sold by Ceva. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares of common stock offered in this offering are expected to be listed for trading on the Nasdaq Global Select Market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The principal purposes of this proposed offering are to increase Ceva&#8217;s financial flexibility, obtain additional capital and to increase its public float. Ceva intends to use the net proceeds from this proposed offering to fund potential acquisitions of, or investments in, complementary technologies or businesses. Ceva may also use the net proceeds from this proposed offering for working capital, capital expenditures, share repurchases and other general corporate purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">J.P. Morgan is acting as lead book-running manager for the proposed offering. UBS Investment Bank is acting as junior active book-running manager for the proposed offering. TD Cowen and Stifel are acting as additional book-running managers for the proposed offering. Needham &amp; Company, Rosenblatt, Roth Capital Partners and Loop Capital Markets are acting as co-managers for the proposed offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The proposed offering is being made pursuant to a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 7, 2024 and became effective on August 16, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the proposed offering will be filed with the SEC and will be available for free on the SEC&#8217;s website located at http://www.sec.gov. When available, copies of the preliminary prospectus supplement and accompanying prospectus relating to the proposed offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com; UBS Securities LLC, Attention: Prospectus Department, 11 Madison Avenue, New York, New York 10010, or by emailing ol-prospectus-request@ubs.com; TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email: TDManualrequest@broadridge.com; and Stifel, Nicolaus &amp; Company, Incorporated, Attention: Prospectus Department, One Montgomery Street, Suite 3700, San Francisco, CA 94104, or by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Prospective investors should read the prospectus forming a part of the registration statement and the prospectus supplement relating to the proposed offering, when available, and the other documents that Ceva has filed with the SEC for more complete information about Ceva and the proposed offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">Page <b>2</b> of <b>3</b></div>
</div>
</div>
</div>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Ceva, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At Ceva, we are passionate about bringing new levels of innovation to the smart edge. Our wireless communications, sensing and Edge AI technologies are at the heart of some of today&#8217;s most advanced smart edge products. From Bluetooth, Wi-Fi, UWB and 5G platform IP for ubiquitous, robust communications, to scalable Edge AI NPU IPs, sensor fusion processors and embedded application software that make devices smarter, we have the broadest portfolio of IP to connect, sense and infer data more reliably and efficiently. We deliver differentiated solutions that combine outstanding performance at ultra-low power within a very small silicon footprint. Our goal is simple &#8211; to deliver the silicon and software IP to enable a smarter, safer, and more interconnected world. This philosophy is in practice today, with Ceva powering more than 20 billion of the world&#8217;s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles and 5G mobile networks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements relating to the proposed offering, including the structure, timing, size and completion of the offering and the anticipated use of proceeds therefrom, and the grant of the option to purchase additional shares. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;upcoming&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed public offering, the risks and uncertainties inherent in Ceva&#8217;s business, including the risks and uncertainties described in the company&#8217;s periodic filings with the SEC. The events and circumstances reflected in the company&#8217;s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Additional information on risks facing Ceva can be found under the heading &#8220;Risk Factors&#8221; in Ceva&#8217;s periodic filings with the SEC, including its annual report on Form 10-K for the year ended December 31, 2024, and in the preliminary prospectus supplement related to the proposed offering to be filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by applicable law, Ceva does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">Page <b>3</b> of&nbsp;<b>3</b></div>
</div>
</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For more information, contact: </b></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5065359477124%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:41.8%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Yaniv Arieli</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Ceva, Inc.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">CFO</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">+972.9.961.3770</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">yaniv.arieli@ceva-ip.com</p>
			</td>
			<td style="vertical-align:top;width:59.3%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Richard Kingston</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Ceva, Inc.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">VP Market Intelligence, Investor &amp; Public Relations</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">+1.650.220.1948</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">richard.kingston@ceva-ip.com</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ex_890611.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html><head>
	<title>ex_890611.htm</title>

	<!-- Generated by ThunderDome Portal - 11/19/2025 12:34:30 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.2</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">PRESS RELEASE</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA ANNOUNCES THE PRICING OF</b><br>
<b>UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK</b>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">ROCKVILLE, MD, November 18, 2025 &#8212; Ceva, Inc. (NASDAQ: CEVA) today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price to the public of $19.50 per share. All of the shares to be sold in the proposed offering are to be sold by Ceva. In addition, Ceva has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Ceva from the proposed offering (before deducting underwriters&#8217; discounts and commissions and offering expenses) are expected to be approximately $58.5 million (assuming no exercise of the underwriters' option).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The proposed offering is expected to close on November 20, 2025, subject to the satisfaction of customary closing conditions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The principal purposes of this proposed offering are to increase Ceva&#8217;s financial flexibility, obtain additional capital and to increase its public float. Ceva intends to use the net proceeds from this proposed offering to fund potential acquisitions of, or investments in, complementary technologies or businesses. Ceva may also use the net proceeds from this proposed offering for working capital, capital expenditures, share repurchases and other general corporate purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">J.P. Morgan is acting as lead book-running manager for the proposed offering. UBS Investment Bank is acting as junior active book-running manager for the proposed offering. TD Cowen and Stifel are acting as additional book-running managers for the proposed offering. Needham &amp; Company, Rosenblatt, Roth Capital Partners and Loop Capital Markets are acting as co-managers for the proposed offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The proposed offering is being made pursuant to a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 7, 2024 and became effective on August 16, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the proposed offering were filed with the SEC, and a final prospectus supplement and accompanying prospectus relating to the proposed offering will be filed with the SEC and will be available for free on the SEC&#8217;s website located at http://www.sec.gov. When available, copies of the final prospectus supplement and accompanying prospectus relating to the proposed offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com; UBS Securities LLC, Attention: Prospectus Department, 11 Madison Avenue, New York, New York 10010, or by emailing ol-prospectus-request@ubs.com; TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email: TDManualrequest@broadridge.com; and Stifel, Nicolaus &amp; Company, Incorporated, Attention: Prospectus Department, One Montgomery Street, Suite 3700, San Francisco, CA 94104, or by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">Page <b>2</b> of <b>3</b></div>
</div>
</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Prospective investors should read the prospectus forming a part of the registration statement; the preliminary prospectus supplement relating to the proposed offering, the final prospectus supplement relating to the proposed offering, when available, and the other documents that Ceva has filed with the Securities and Exchange Commission for more complete information about Ceva and the proposed offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About Ceva, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At Ceva, we are passionate about bringing new levels of innovation to the smart edge. Our wireless communications, sensing and Edge AI technologies are at the heart of some of today&#8217;s most advanced smart edge products. From Bluetooth, Wi-Fi, UWB and 5G platform IP for ubiquitous, robust communications, to scalable Edge AI NPU IPs, sensor fusion processors and embedded application software that make devices smarter, we have the broadest portfolio of IP to connect, sense and infer data more reliably and efficiently. We deliver differentiated solutions that combine outstanding performance at ultra-low power within a very small silicon footprint. Our goal is simple &#8211; to deliver the silicon and software IP to enable a smarter, safer, and more interconnected world. This philosophy is in practice today, with Ceva powering more than 20 billion of the world&#8217;s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles and 5G mobile networks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding Ceva&#8217;s expectations of market conditions and the satisfaction of customary closing conditions related to the public offering, and the expected closing of the proposed offering and the anticipated use of proceeds therefrom. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;upcoming&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed public offering, the risks and uncertainties inherent in Ceva&#8217;s business, including the risks and uncertainties described in the company&#8217;s periodic filings with the SEC. The events and circumstances reflected in the company&#8217;s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Additional information on risks facing Ceva can be found under the heading &#8220;Risk Factors&#8221; in Ceva&#8217;s periodic filings with the SEC, including its annual report on Form&nbsp;10-K&nbsp;for the year ended December 31, 2024, and in the preliminary prospectus supplement related to the proposed offering filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by applicable law, Ceva does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">Page <b>3</b> of <b>3</b></div>
</div>
</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For more information, contact: </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5065359477124%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 42%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Yaniv Arieli</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Ceva, Inc.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">CFO</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">+972.9.961.3770</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">yaniv.arieli@ceva-ip.com</p>
			</td>
			<td style="vertical-align: top; width: 58%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Richard Kingston</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">Ceva, Inc.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">VP Market Intelligence, Investor &amp; Public Relations</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">+1.650.220.1948</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 9pt;">richard.kingston@ceva-ip.com</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ceva-20251117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/19/2025 2:10:53 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ceva="http://www.ceva.com/20251117" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ceva.com/20251117">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20251117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20251117_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20251117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.ceva.com/20251117/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="ceva_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ceva-20251117_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/19/2025 2:10:53 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.ceva.com/20251117/role/statement-document-and-entity-information" xlink:href="ceva-20251117.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.ceva.com/20251117/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ceva-20251117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/19/2025 2:10:53 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line Two</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ceva-20251117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/19/2025 2:10:53 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.ceva.com/20251117/role/statement-document-and-entity-information" xlink:href="ceva-20251117.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.ceva.com/20251117/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>mflogo.jpg
<TEXT>
begin 644 mflogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _J;^-/\
MP57\$?!C_@JC^SE_P2TU#X1^*]<\:_M%_!6#XT:3\6++Q%H]KX6\,Z=/KOQ>
MT,:)J7A^XM'U:^O%D^$6H7#75K>1P[-8LT6(M;SEO'_@S_P6U^'/QD\?_P#!
M5_P%I_P*\;Z)<_\ !*>T^,MWXWU&\\5Z#=6_Q<7X.7/Q&MM03PK#!8QR^'7U
MMOAU>-9'5C>K;+J-MYY=H9 WY7_MU$#_ (.\_P#@F'DX_P",$+ ?C_PG_P"V
MKQ6C\,O^"<_[4G[)&I_\'.?[2/QK\+>'-$^%/[8'PQ_;0^(/P/U72/&6@^(=
M3USPSJVF?M >,+*ZU?1-+N9K_P .SOHGB72YGM-5C@N(YY);9H_,A? !^T'[
M%'_!6[X$?M9?\$[M8_X*3^-=&OOV;O@AX5'Q%N_&2>/=<LO$%SX<TCX;WS6&
MHZB]WH-E&=3GU2<);Z+HVFZ?/K&J:C<6>DZ?9WFHWEK;R_C3>_\ !U9XDN=*
MU3X_^#/^"0_[:?BW_@G]HVMW%A??MB)<2Z=;#1K*\DL[WQ'%X+3X<:EX(&GP
M-!<>8]Y\;[*TMKA$L-3O].OVDMH?S?\ V6/V>OC'^TW_ ,&>'Q*^''P+TK6/
M$_CK3_B1X_\ B"_@KP^E[<ZWXV\-_#KXQZ3XM\3^'M*TZQ<3:SJ2Z/IEQK>G
MZ&D5U<:O>Z-;V&G6=SJT^GQ-^H/P%_X.,/\ @D#X._X)4>![#Q#XVTOPIXQ^
M'W[-6C_!W7OV+?\ A"/$%YXXN_&7A[X?IX/O/A[HNE2Z/-X:UKPGXCU"SE2U
M\8ZEK47AXZ-J,=SXNOM)UAM2TN  _73]HC_@KO\ L\?"'_@F!J__  54^%^G
M:M^T%\"K70OA_KVCZ'X7O[3PMXDU1/'?Q'\+_#2;2K_^WK>9/#^N^$]:\2NO
MB+2M0MGN+>?2+VSA\QI+>>3\;[;_ (.O(=&\+:+\5_BC_P $DO\ @H'\.?V?
MK^/1=3U3XYW'A*>^\#:;X9UVXM[?3_$MIK>J>%/#'A;5].O&NH&T]T\5V<.I
MF6**QN9IIH8Y/R^@_9X^,?[/'_!FS^T9;?&71]9\'WGQ6^(W@#XQ>!OA]KL-
MY:WG@SX>>-/VI?@F?#$ M-2NKC4K*+Q'%8S>*K>UU&.VO_LVM6]S<I++=-<2
M_,_[7?PG_P""W7P6_P""/W[/OQ&^-?[>NE^/?^":OQ<\)_ 3X?\ Q,^%_P (
M/ 'ARU^('PE^ 'C^TTP:/+XDOW^&'A;6-?T73HDTWPEJ=I9^.;N;6-9U71]+
MU/[?HNH:C=6P!_:5_P % /\ @L+\&_V(_P!A[X0_MW^%_ /B7]I7X6_'+7?A
MKIGPYT[X>ZQ8:'J>OZ7\4]#N]?\ #.MVDFK6-[YHGM+:*(:8EH;V2ZN8X %=
M7K\O])_X.G/#'@SQ'X,G_:W_ ."8?[>W[(/P8\5>)=)\+7_QX^*'P^U:/P3X
M5O\ 7'VZ?=ZLFL>%?")O=.1!)>WT>B7NIZXFFV]S=:9H>KRP_9G\&_X.!_A_
M\,_ 7_!"W]@+X:_LJ>,8]3^%?ASXO?L?>&/@+X^N[^+75OO#-OX/U&T\">++
MV^C2[AU!YH#8:M>E(9T:0S1B!@ODU^9G_!5+]G?_ (*L?#B3]B#X3_\ !93_
M (*&6/QE_P""</Q__:'\$>'_ (K^+_@GX \$^&X?A;J&E+:SZ#/XQNY/AO\
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MD:9XGAD\1W4?_"P9=;^&EW!HEK=7[1?V4]A<(U\J:;'-(WE/$* /[]OV1O\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">CEVA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Nov. 17,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-49842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">77-0556376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">15245 Shady Grove Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity, Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">308-8328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CEVA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001173489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ceva20251118_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ceva.com/20251117/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ceva-20251117.xsd</File>
    <File>ceva-20251117_def.xml</File>
    <File>ceva-20251117_lab.xml</File>
    <File>ceva-20251117_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="ceva20251118_8k.htm">ceva20251118_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ceva20251118_8k.htm": {
   "nsprefix": "ceva",
   "nsuri": "http://www.ceva.com/20251117",
   "dts": {
    "schema": {
     "local": [
      "ceva-20251117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ceva-20251117_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ceva-20251117_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ceva-20251117_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ceva20251118_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 37,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.ceva.com/20251117/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ceva20251118_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ceva20251118_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ceva.com/20251117/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001437749-25-035656-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-035656-xbrl.zip
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M/5)D.#H?PXL?8R)'J-_D@B<75.7BR[_WE!.^%"-:2.A:2I5ZVS*MSBM)Y$
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MT.OOAD'.F,<$#9E#>E/2U< [ >"1*U^$U"4&L2RP@8H(R5?-_6JA2.KGQ##
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MEJV*U_"DE66 5E& *!R64^XCD"N(RQY;92D.DG'D*$KKB^ XX8*!12*$>^Z
M+1:QU8>&[9+1KW3C&X_2ILV8$12YHZ5.9=7!>RJ3P'I1K@=JWC0O*\/S#0&]
MM(VI;\F%3;=4F@E]:V@J725[(9U'14JXC2 $/$H20- #FS^B&%1IIMH,U4NB
M,5E#S+H6P=V716SNJT,[  ?)0U.I(T!+03:"*)= J\H>)40L2D-<D//P\0@5
M"^]6KS;A;Q EKIN6,%8K7QP84DI=*YW0>VLTIS2L&ZP39R ;@+TRKM7K>U3:
M]3O5+' 3)$!8?=Z(Z;2;[^<=K9DBBZ3@)TY5%-XKV>Z$#DFC1/!/;!P\I+?U
MAO3:7DA+_(HX(/D%"P;Z>$XW2[$DD1&_+%*4J0,!_- ;>=1M-*H"V(/>@\S#
M#EN$"53FZ2G5O'4>WF8L,R0"\HF<-L(MQA8J2X11? B1CBP2>Q=97!:Z<H!C
M%RIXC^CN BT0&=1VKUX@(3!2JFQ52:/DMZ9A#61W%.)+JVJ(@&E63:MRNU.0
M\Y]:VW]J;4^MM6V7M;92('^\X/8OU<%$]>_U\U7=SJHNPI*QL:E&N+U:"N?9
M,80;?[/1WA DRO(EXOEWEW$ X.^_G^!PG7N[K=WVJ]WMW?V=O;W.ULYWAW7+
MH7E+=D,).+V[_.+EBQ='/L<'^AE7QT\0UBEE*17'VZP\9J?3>OT=+\3\KY8[
MBGV6]*_(\R:BFVNX\R#/YSBU7DQ]MC//KI[OL/_:W]MJ[;?V7W5:VWM[[><[
M>$;WV9)\GS]%$'-39]1090J(@$T?/UD3=_=;V\^FB3>:?@$A%N\)2'EKOFUM
M_/FZ?-$)YWKX)SVBEWX;Y0M@E-YQ&_\Z9!DW7'I .O*,&MQIO=IMMX"$6YW]
MG=?/=W >]*!U5^K!8UJ,G^17$?LX"/P%J.JBV[]M+G#(6ISTI^*?*LSC _V&
M#8(@_ZK0_P-02P,$%     @ R4-S6ZN >XL8#   ""\   T   !E>%\X.3 V
M,3 N:'1MW5IK<]JX&OZ\_17:[-EN.F,(D*1- \T,39-NIKE-R)Y^/"-L =K8
MEBO+$/;7G^>59&.@M"?;IF?;SJ2 ++WWN]R;F"0^ZDT$CXZ>_-0STL3B2-S_
MY^!EZWF[U<33WHY;?/(3GO_<:+"W(A6:&Q&QX9S=3HHT$OJ-2@2[5MKPF#58
MN[W3?KG3:77V6?MP?_^PO<?Z%ZS1..HEPG 63KC.A7FU59A1XV#+KZ8\$:^V
M1DHGW#0B841HI$JW6*A2(U+L-B(6V42EXE6JMHZ>]'8<T;VABN8L-_/8'D]-
M(Y=_B4/6;F6FR^S"B"<RGA^RIQ\*9;JW,A$YNQ0S=J,2GKK%+LMX%,ET?,A:
M,F6M9ENF7186.E?ZD/'"J"[AS$I$"==CF6)S=L\L(B/N38/'<HQ%+<>3$O??
M(@8RH;U+7)7G?ELY\EO [$K <J'E: TM8 V/3NXG<B@-VV^V>SO#H]X.;<)'
M=O3D?V4J%J-_$$]/TV&>=9?Y,'P8"S94&@;Y:JL%TQ%Q[-5:_<XS'I:_O]1H
M5JF<R<A,"$CK5[(6. P\2N,+?48E.K]K;__7+IL*;63(XU+(1F7V) Y$<GK4
MD\F8\1C&GXQB-5;-/[,QR-;AT@+XI\WVU(Z)-N#KO/@TONRCFEGA>Y,!3+F6
M/#6'+"7_C;ML84H&"/80"2[Z-^].;MG@]N;DY+8W=&(9]"_9Z4W_\OAL<'Q5
M+A[WS\].KVXNS_I.R^SE7KNUW^CL'72<IA^;W-*XO@6NVY/SD^O?KRY/8!'M
M_6;G^4'S1:O5^C;(3_O'@[.+L_,Z\OW.#RCE]^_?-R^N3J^:QU<7%N-G?.7@
M6_A*#D+C1LBS?)7<1&DM<Y6RISS)Z)C0N1&:(9Q];7EM)N)Q]+,9'T^(QX@G
M ?)M;F0:L*'0L?U4N5'TJ8L\%S$B;B12Z"=@J ?&[ [_!2Q6:42;8I4SGHY1
M+6!?(D%GP%+0-U?Z+D":CQ6%5(6HS5,623'V7T>:IZ',0_HY 8 )Q\$<N8)G
M2HL ^K^;X]F,YQ,L6GJB9MA<-2=\4AA#?6+ST5*"K4MN57 +N5FQ+4FM)C0O
M,VQAY=_!FKJ^'*-WHP4V8+A44Y% ):Q]$#"J[CZ%;"VE/QC=XS/T6G$=,35B
M;Z1&N:ET_IC8CL64!^PLA<E0HFOO=_;VV6#"4;V^U1 MP/(H8(-"&L'VRA3P
M.+3<J/!N*N,89GW!]3SF:02-'NQ_$NGWH-(;A)U><71=#&,9LJO1")49(@1T
M?*R2!!%U8,!Z;Z=8*WZ_-T[/.6(71;J(.C)T:(E(#[]OIFR[(=%/XFEGWR5N
MP;C&'YI!J)'G: >+%"D T9@M' H9@[T1,9_1WE!I!&Q.W2/;-A/!GOYRT.FT
MNFB#8 ,93^?4 MG%=O=9P-#NH<=,7;^)&MY,&)V2>5X@(0@KX9Q39S&W#SP0
MLJDB(SIV Q1L]$=Y0X-_/)&&2+46EY/%!>Q?K6:KU4;^T6S*XT*P#)'4'EBE
M<F"A+!.)^$]@9Q,93IC;8 4#]$/!<A5'J^1EZ%W!@*$MG&5:Y1E8+'*6%UEF
MK<6PR+;Q:W'=LDRP>!@Z:"3\(<]%'8X[W"_&2-:L_=P>W6/;>0$*(Q46A $9
M.%0(,Y#M5,3S@"US>EU!JW.+3=PPF@20M SQ76.,=K5?=',FX-P6+KL18YD;
MK_*! 5V6._PX)2"#QB[;/I70X*5J.AO>W=UM= [:NYW=9ZO2_SBP96V, &Q-
MX)7E_)%*DHP]F[.!" LM3>FK)_<A%1?V6 (;^[B5^B=+4K&#%HN@!K(?6OFT
M7^[N!N0>',1&0+YJ4DLGZF";/US(N)U(N& F4Q(MO@X%6>^HT*G,)Q#-!G_7
MXD.!,L!:+8GT#(IGSUOM[>&S[?UGM ++*&)O%XUW&_416#VGJDZ#N,_@L3FP
M3X0&/:0J\DN83<(-E?:(!H9C/TC% X+J!U]Y:?^;K-S1L'"E@"DLT"JW>#SN
MF(9DUF4]"99S/*%3)4X767X\F^@O$L?("\R[+0IZP28<443< WD*^2@M 8K'
M.<DVA!:ID0BI&QQ)^]@)>"81#R5A<>L0H2H0TJ&@?,2M=06D.QL0^5@+X2.B
M3*'&,CS6(Z5#$=JP03:$HE3I*"<EED1&!(6>Q$A^T+XU-1%"ORCC*MX0^S.5
MNTRD*2#8(LC4'8,.SEQRM4*7R$N5+R#*AT+0W QFRN^$VXY5@AKYI.,>K 3!
M#<[%"S.!6/_B3BKKN=7;N+<_)'4K2Z<2?Z@4 <=AR."0;<MG%7#20BB-S<JE
M_A:RK1+:6*0%=)Q"7K23LFJ.YIZ; FB[@.A!@@?*/P2PXJ%F%N[D GQ>#+'7
M.-$4N:M3R&XL2 \3.C>3@')JH7DXMS11>HV%J0BRA4?JAN"6:2W(>8'$_G:,
MH,I!JVK##<4(;HT6@K>R^!([LWFW%+,64REF(NK:+=MRZKB(Q1B212O*2W&3
M**P$L8XHEH/,)NN[^(9'+KY9[L@K@AJ"V+I3ZL/O.J-Y&>2JTX 6B9+7FOQ5
M16Y06K;%D2K#*!)DPH8#Q$"14UON,@&\94J36^N]$V$Q>&">M"9;RB90%<5J
MK(Q1=Z0.ES6B!:5E@(=C$;%!2:T-Y_=5-0,=B[&"AWW+8!O)*0MC.-"KK>NW
MK]]MK8R][.#:3V4:-.]WHYERQ5YKV"6Z"EF"=7I[4P&K7QJ$$(G02Y/QE;.3
M44.KV?HBS>K9]=O+/RX6/-@I]_+'D]Y$EXBO^V]/&J]O3OKO&OW3VY.;0ZAF
MQN=P0G<G0,/!5"R/Z:$NQU4GN^]2K4K7/;^T[#^<X^'=6"-Q1(WE1VL"^/W-
MQP7@;DW^)ONW5\?G,KW[I  J.=#YM7N<!]V K4[NMAYX__ X-"SQ_C@H-CC?
M5YH]/VS*])60UH9-CX_L08/!KX3SFJ.'NIVIS7>87WA;60N<E?']'QJ81<JA
M_CORC4,MJ<9\1OT_NNLRE5:3$'=3'Z,X6TQ$SOFLWB@VV7M1=@CUGF6M37$]
M!0#3=2>R76&H*D9<14F$2@[?=1$+6S+KJD]RA4"QZ'O<  "D)V5S^A!B?<^*
MC!K&121R"\P1HU#]HCZ=RMQ6#XNZR)2(*4WS+(M1]] U<6VSS\@5)<=8-!)
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M+!;%1?45,V.4Y/;_^C;X<)]GT/U?8EVGP#J%0;\#!B;63?,3WP9W,K!=P.2
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M!E2]ZHQWVL[>>*DFE]W8O;4;6PI0^A'_K$3E:,C0&[DF,5<-XHO$>5X4,V\
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MW;:Z X;Q,15/K#==\8^!%VY0GI4IVB)#&/*9SMJ'2L6]"VT[UCE>9S*;X]/
M6#M9"I8%J\*+AO9V<9FF@66'54:F^QIG57G /EC2P%IS6 .<UWRP1MQ7*_<
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MF:UG@XXSGDHM/XH0YNW35A:0IGVT7Z3R!%F13VSWI>N;[#,CMQ,5U)>FD[/
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M:;?RI'2Q]LJRZUHM$7 B)K]:9W9KUC^U1+8.<M]9C!(68#/E59@9=MD#ND_
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MBU 1)K&R,W>]FLRN(4%N,+_R+ LU-;<2+R!N)L1J^DWS%"B916^BN(W%(3O
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MT!#,/%E5IAQ&Y]163\>GHKEW:U?HXU!!]["=<^>S<BGIW5&"EVV"O.WP2*G
MLVHJA7XB;U!/Y]J19:+'2,HLB\Y83>70*]]@[LT2#$(T1 )]Z]*;9E=(1M-,
M??0ONAQ;1:4R2+ &EFNN*;W2]Y.FW^,_?#20HH?GD;D#*:9<A>8!.MDO0T;
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M><#[XJ*M7>Z&(?S\1(M;LY[^:MTP=\B=D-1=;9W]U^_;-W[QID5)F\/N6P=
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MU"#PJT0ZZ8R'(B@[ )/)FN5276VM)^ /'S"-NXP/LW 4V%3E(.:7<29_57<
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MYW0#X)W%ZAM^T3^^>4#>67S [9)WAGYD;M%QEP83^_L?35$?MV;''[:F"%8
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M>7_-:SU7R  ]7R(7"&^B]9,"&)MK,$D*$"T#<[D,8?XMD(B1!H2A(!)+XZ(
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MLBO_ 5!+ 0(4 Q0    ( ,E#<UMVW=O@@ ,  !H.   1              "
M 0    !C979A+3(P,C4Q,3$W+GAS9%!+ 0(4 Q0    ( ,E#<UM^8K)IZ00
M &<N   5              "  :\#  !C979A+3(P,C4Q,3$W7V1E9BYX;6Q0
M2P$"% ,4    " #)0W-;$9>9)A$&  !L/@  %0              @ '+"
M8V5V82TR,#(U,3$Q-U]L86(N>&UL4$L! A0#%     @ R4-S6S<\2ZZ$!
M-B\  !4              ( !#P\  &-E=F$M,C R-3$Q,3=?<')E+GAM;%!+
M 0(4 Q0    ( ,E#<UOA';D?01$  #]T   3              "  <83  !C
M979A,C R-3$Q,3A?.&LN:'1M4$L! A0#%     @ R4-S6Q/*J9L'#P  ,30
M  T              ( !."4  &5X7S@Y,#0S-RYH=&U02P$"% ,4    " #)
M0W-;JX![BQ@,   (+P  #0              @ %J-   97A?.#DP-C$P+FAT
M;5!+ 0(4 Q0    ( ,E#<UM35,-U(P\  .@V   -              "  :U
M  !E>%\X.3 V,3$N:'1M4$L! A0#%     @ R4-S6QBM509L>P  Y_4"  T
M             ( !^T\  &5X7S@Y,#8T,"YH=&U02P4&      D "0 U @
&DLL

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ceva20251118_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ceva-20251117.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
        </entity>
        <period>
            <startDate>2025-11-17</startDate>
            <endDate>2025-11-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-252">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-253">0001173489</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-263">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-264">2025-11-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-265">CEVA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-266">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-267">000-49842</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-268">77-0556376</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-269">15245 Shady Grove Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="d20258K" id="ixv-270">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-271">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-272">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-273">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-274">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-275">308-8328</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-276">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-277">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-278">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-279">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-280">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-281">CEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-282">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-283">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
